Somatostatin and SMS 201-995 (octreotide): clinical and therapeutic aspects.

Authors

  • P M da Silva Serviço de Medicina Interna, Hospital de Santa Marta, Lisboa.
  • F Augusto

DOI:

https://doi.org/10.20344/amp.3053

Abstract

Nowadays, the digestive system, must be considered as an actual endocrinous gland. The authors, after pointing out the pharmacological and immunomodulating actions of endogenous somatostatine, briefly describe a new synthetic octapeptid, somatostatine-analogue, with similar pharmacological effects (octreotide). Finally they stress the therapeutic trials in which the adverse effects, dosage and administration have been studied.

Downloads

Download data is not yet available.

How to Cite

1.
da Silva PM, Augusto F. Somatostatin and SMS 201-995 (octreotide): clinical and therapeutic aspects. Acta Med Port [Internet]. 1993 Jan. 30 [cited 2024 Mar. 29];6(1):25-31. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/3053

Issue

Section

Arquivo Histórico